SCRS Launches Diversity Awareness Program
Ellicott City, MD - The Society for Clinical Research Sites (SCRS) has recently launched an innovative new program, “Site Awareness and Best Practices for Inclusion of Diverse Populations in Research.” The program is aimed at developing a better understanding of the knowledge, expertise, and best practices at clinical research sites to meet the needs of an increasingly diverse United States population.
The project has been advocated and is being sponsored by the following industry leaders: Merck has signed on as the Premier Supporting Sponsor of this program, and additional sponsors include Janssen and the Pharmaceutical Research and Manufacturers of America (PhRMA) as Contributors, and Acurian at the Patron level.
This diversity awareness program was created to support efforts by research sites to meet the goals of the FDA’s Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data. The FDA’s plan prioritizes improvements in the quality of demographic subgroup data collection, reporting and analysis, encourages greater participation of diverse patients, and supports the transparency of subgroup data.
“We know that clinical trials often fail to recruit minority patients in sufficient numbers for subgroup analysis,” said Christine Pierre, President of SCRS. “Our members include sites with innovative and successful minority patient recruitment programs, and SCRS is in a unique position to gather and share the best practices from those sites.”
To find out more about becoming a sponsor of this program, contact Diana Foster, Vice President of Strategy and Development of SCRS, at diana.foster@myscrs.org.
About SCRS
SCRS is a global trade organization founded in 2012 which represents more than 4,000 research sites in 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
